
Docusign Inc. (NASDAQ:DOCU – Free Report) – Analysts at Zacks Research increased their Q4 2027 EPS estimates for shares of Docusign in a report issued on Thursday, June 25th. Zacks Research analyst Team now anticipates that the company will post earnings of $0.46 per share for the quarter, up from their previous estimate of $0.45. The consensus estimate for Docusign’s current full-year earnings is $1.97 per share.
Docusign (NASDAQ:DOCU – Get Free Report) last issued its quarterly earnings results on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10. Docusign had a net margin of 9.59% and a return on equity of 17.48%. The firm had revenue of $830.24 million for the quarter, compared to analysts’ expectations of $824.71 million. During the same period in the previous year, the firm posted $0.90 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis.
Check Out Our Latest Stock Report on Docusign
Docusign Stock Performance
NASDAQ:DOCU opened at $45.31 on Monday. The stock’s 50-day simple moving average is $47.01 and its 200 day simple moving average is $51.62. The company has a market cap of $8.65 billion, a P/E ratio of 29.43, a P/E/G ratio of 1.37 and a beta of 0.92. Docusign has a 52-week low of $40.16 and a 52-week high of $86.65.
Institutional Investors Weigh In On Docusign
Several hedge funds have recently added to or reduced their stakes in DOCU. EverSource Wealth Advisors LLC increased its holdings in shares of Docusign by 15.1% in the third quarter. EverSource Wealth Advisors LLC now owns 1,229 shares of the company’s stock valued at $89,000 after purchasing an additional 161 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Docusign by 8.2% during the 2nd quarter. Smartleaf Asset Management LLC now owns 2,169 shares of the company’s stock worth $166,000 after buying an additional 165 shares during the last quarter. Centaurus Financial Inc. boosted its holdings in shares of Docusign by 3.4% during the 3rd quarter. Centaurus Financial Inc. now owns 5,582 shares of the company’s stock worth $402,000 after buying an additional 184 shares during the period. Clearstead Advisors LLC boosted its holdings in shares of Docusign by 12.1% during the 3rd quarter. Clearstead Advisors LLC now owns 1,872 shares of the company’s stock worth $135,000 after buying an additional 202 shares during the period. Finally, Tred Avon Family Wealth LLC grew its stake in Docusign by 3.6% in the 1st quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock valued at $293,000 after buying an additional 215 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
Insider Transactions at Docusign
In other news, CEO Allan C. Thygesen sold 26,250 shares of Docusign stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $47.78, for a total transaction of $1,254,225.00. Following the completion of the transaction, the chief executive officer directly owned 152,237 shares in the company, valued at approximately $7,273,883.86. The trade was a 14.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mary Agnes Wilderotter sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $48.15, for a total value of $144,450.00. Following the transaction, the director directly owned 59,803 shares in the company, valued at $2,879,514.45. The trade was a 4.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 64,695 shares of company stock valued at $3,006,682. Company insiders own 0.59% of the company’s stock.
Docusign declared that its board has authorized a stock buyback plan on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 21% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
See Also
- Five stocks we like better than Docusign
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
